1. Home
  2. RNAZ vs STSS Comparison

RNAZ vs STSS Comparison

Compare RNAZ & STSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNAZ
  • STSS
  • Stock Information
  • Founded
  • RNAZ 2016
  • STSS 2017
  • Country
  • RNAZ United States
  • STSS United States
  • Employees
  • RNAZ N/A
  • STSS N/A
  • Industry
  • RNAZ Biotechnology: Pharmaceutical Preparations
  • STSS Medical/Dental Instruments
  • Sector
  • RNAZ Health Care
  • STSS Health Care
  • Exchange
  • RNAZ Nasdaq
  • STSS Nasdaq
  • Market Cap
  • RNAZ 6.1M
  • STSS 5.8M
  • IPO Year
  • RNAZ 2021
  • STSS 2022
  • Fundamental
  • Price
  • RNAZ $8.73
  • STSS $5.85
  • Analyst Decision
  • RNAZ Strong Buy
  • STSS
  • Analyst Count
  • RNAZ 1
  • STSS 0
  • Target Price
  • RNAZ $280.00
  • STSS N/A
  • AVG Volume (30 Days)
  • RNAZ 24.7K
  • STSS 143.8K
  • Earning Date
  • RNAZ 08-13-2025
  • STSS 08-13-2025
  • Dividend Yield
  • RNAZ N/A
  • STSS N/A
  • EPS Growth
  • RNAZ N/A
  • STSS N/A
  • EPS
  • RNAZ N/A
  • STSS N/A
  • Revenue
  • RNAZ N/A
  • STSS N/A
  • Revenue This Year
  • RNAZ N/A
  • STSS N/A
  • Revenue Next Year
  • RNAZ N/A
  • STSS N/A
  • P/E Ratio
  • RNAZ N/A
  • STSS N/A
  • Revenue Growth
  • RNAZ N/A
  • STSS N/A
  • 52 Week Low
  • RNAZ $6.15
  • STSS $3.36
  • 52 Week High
  • RNAZ $905.52
  • STSS $2,224.20
  • Technical
  • Relative Strength Index (RSI)
  • RNAZ 52.29
  • STSS 47.57
  • Support Level
  • RNAZ $8.28
  • STSS $5.51
  • Resistance Level
  • RNAZ $9.15
  • STSS $5.95
  • Average True Range (ATR)
  • RNAZ 0.61
  • STSS 0.31
  • MACD
  • RNAZ 0.23
  • STSS 0.17
  • Stochastic Oscillator
  • RNAZ 57.63
  • STSS 79.73

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.

About STSS Sharps Technology Inc.

Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes designed to eliminate potentially infectious and accidental needlestick injuries.

Share on Social Networks: